|
Other issues |
Survey prize winnersCongratulations to
who have each won a £25 voucher (from M&S or amazon.co.uk) in the readership survey prize draw. Clinical Pharmacist would like to thank everyone who contributed their views via the survey. |
Opinion
Does it do what it says on the tin?
L Mellor
CP 2009;1:466
Editor’s choice
Staffing woes could spoil the plans for high-level practice
M Wright
CP 2009;1:466
Update
NHS pharmacy vacancies reveal training gaps
CP 2009;1:467
Auditing antibiotic prescribing may overburden hospital pharmacists
CP 2009;1:467
Adding cetuximab to radiotherapy benefits head/neck cancer patients
CP 2009;1:468
Capecitabine may cut breast cancer recurrence
CP 2009;1:468
Darbepoetin risks for diabetic patients with renal disease and anaemia
CP 2009;1:468
Mental health pharmacy groups to merge
CP 2009;1:468
New NICE assessment process for medical technologies
CP 2009;1:468
Simpler lipid assessments suggested
CP 2009;1:468
Nicotinic acid with statin therapy “promising”
CP 2009;1:470
High-dose losartan beneficial for heart failure patients
CP 2009;1:470
News feature
Accreditation of advanced practice is on the horizon
G Malson
CP 2009;1:471-472
Columnist
Reflections of an independent prescriber
But do I add value?
S Marsh
CP 2009;1:471-472
Clinical focus
Type 2 diabetes: Pathophysiology and clinical features
E Hackett, N Jacques
CP 2009;1:475-478
Type 2 diabetes: Management
N Jacques, E Hackett
CP 2009;1:479-482
Lifelong Learning
CP 2009;1:483
Practice tools
How to use “trigger drugs” to help identify adverse medication events
G Cavell
CP 2009;1:484-485
Spotlight on medicines
Ustekinumab
C Herring
CP 2009;1:486-488
FAQ
Treatment of psoriasis with fumaric acid esters
CP 2009;1:488
Short communication
Cost savings from using patients’ own drugs in a paediatric hospital
A F Asare, A Safdar, S Tomlin, P Hayes
CP 2009;1:489-490
Consultant pharmacist
Working to reduce medication risks as a champion of elderly care
L Oboh
CP 2009;1:491-92, 495
Guild Matters
December 2009 newsletter
CP 2009;1:insert

